Telix Pharmaceuticals (TLPPF) Inventory (2023 - 2026)

Telix Pharmaceuticals (TLPPF) has reported Inventory for 4 consecutive years, with $39.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Inventory changed N/A year-over-year to $39.0 million in Q2 2026; TTM through Jun 2026 was $39.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $37.1 million, up 56.99% from the prior year.
• Inventory was $39.0 million for Q2 2026 at Telix Pharmaceuticals, up from $37.1 million in the prior quarter.
• Over five years, Inventory peaked at $39.0 million in Q2 2026 and troughed at $11.3 million in Q4 2023.
• A 4-year average of $28.1 million and a median of $31.0 million in 2025 frame the typical range for Inventory.
• Across the five-year window, Inventory soared 121.36% in 2024 and soared 48.65% in 2025, its largest moves.
• Over 4 years, Inventory stood at $11.3 million in 2023, then soared by 121.36% to $24.9 million in 2024, then jumped by 48.65% to $37.1 million in 2025, then climbed by 5.26% to $39.0 million in 2026.
• The last three Inventory figures came in at $39.0 million (Q2 2026), $37.1 million (Q4 2025), and $24.9 million (Q4 2024), per Business Quant data.